[{"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q3_USD":23020000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-7545000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":236000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-533000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-533000.0,"OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax_3_Q3_USD":-533000.0,"OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax_1_Q3_USD":-533000.0,"OtherAssetsMiscellaneousNoncurrent_0_Q3_USD":490000.0,"OtherAssetsCurrent_0_Q3_USD":96000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-10709000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":23576000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":2335000.0,"OperatingIncomeLoss_3_Q3_USD":-155608000.0,"OperatingIncomeLoss_1_Q3_USD":-54527000.0,"OperatingExpenses_3_Q3_USD":155608000.0,"OperatingExpenses_1_Q3_USD":54527000.0,"NetIncomeLoss_3_Q3_USD":-166279000.0,"NetIncomeLoss_1_Q3_USD":-62059000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-125802000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":34752000.0,"OtherPrepaidExpenseCurrent_0_Q3_USD":1587000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":9431000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":3751000.0,"StockholdersEquity_0_Q3_USD":629080000.0,"ShareBasedCompensation_3_Q3_USD":17455000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-557189000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":4200000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":114014000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":40159000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":28404000.0,"ProfitLoss_3_Q3_USD":-166279000.0,"ProceedsFromWarrantExercises_3_Q3_USD":55463000.0,"ProceedsFromRelatedPartyDebt_3_Q3_USD":15625000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":328251000.0,"PrepaidInsurance_0_Q3_USD":443000.0,"PrepaidExpenseOtherNoncurrent_0_Q3_USD":1781000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":5353000.0,"PreferredStockValue_0_Q3_USD":null,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-9431000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":421286000.0,"LiabilitiesCurrent_0_Q3_USD":30800000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":733480000.0,"ClassOfWarrantOrRightOutstanding_0_Q3_shares":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":286053000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":673876000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":673876000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":669676000.0,"AssetsCurrent_0_Q3_USD":675029000.0,"Assets_0_Q3_USD":733480000.0,"AssetImpairmentCharges_3_Q3_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":16332496.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":17455000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":6134000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":6134000.0,"AdditionalPaidInCapital_0_Q3_USD":1186787000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-533000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":1546000.0,"AccruedSalariesCurrentAndNoncurrent_0_Q3_USD":8076000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":1472000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q3_USD":23020000.0,"AccountsPayableCurrent_0_Q3_USD":5445000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":132971450.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommonStockSharesIssued_0_Q3_shares":147135968.0,"Liabilities_0_Q3_USD":104400000.0,"InterestIncomeOther_3_Q3_USD":38000.0,"InterestIncomeOther_1_Q3_USD":13000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-1672000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":651000.0,"IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_3_Q3_USD":2806000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":1874000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-166279000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-62059000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":41594000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":14368000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.25,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.43,"DepreciationDepletionAndAmortization_3_Q3_USD":1644000.0,"ContractualObligation_0_Q3_USD":0.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-166812000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-62592000.0,"CommonStockValue_0_Q3_USD":15000.0,"CommonStockSharesOutstanding_0_Q3_shares":147135968.0,"CommonStockSharesAuthorized_0_Q3_shares":500000000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":144022109.0,"Ticker":"CERE","CIK":"1805387","name":"CEREVEL THERAPEUTICS HOLDINGS, INC.","OfficialName":"Cerevel Therapeutics Holdings Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4823550476.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20211110"}]